Pediatr. praxi. 2013;14(1):51-53

Rotavirus gastroenteritis - significance and options of prevention

MUDr.Jan Pavelka1,2, MUDr.Lenka Krbková, CSc.1,2, MUDr.Lukáš Homola1,2
1 Klinika dětských infekčních nemocí, FN Brno
2 Lékařská fakulta Masarykovy univerzity, Brno

We performed a retrospective analysis of the etiology of acute gastroenteritides (GE) in patients hospitalized at the Department of

Pediatric Infectious Diseases of the Brno University Hospital in 2011. Rotavirus was shown in 35.8 % of them, with 91 % being children

up to five years of age and 73 % children up to three years of age; the majority of patients were between six and 30 months old. Typically,

most of the patients were hospitalized during the period December to May. Rotavirus is the most frequent causative agent of GE as well

as pediatric death in the world. Worldwide, an average of 611,000 children die of RVGE annually, most of them in developing countries.

In developed countries, the economic and emotional/social burden is an issue. An effective method of prevention is vaccination.

Keywords: rotavirus, gastroenteritis, RotaTeq, Rotarix, efficacy

Published: February 15, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pavelka J, Krbková L, Homola L. Rotavirus gastroenteritis - significance and options of prevention. Pediatr. praxi. 2013;14(1):51-53.
Download citation

References

  1. Vesikari T, Matson D, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006; 354: 23-33. Go to original source... Go to PubMed...
  2. Parashar U, Bresee J, Gentsch J, et al. Rotavirus. Emerg Infect Dis. 1998; 4(4): 561-570. Go to original source... Go to PubMed...
  3. Simpson R, Aliyu S, Iturriza-Gómara M, et al. Infantile viral gastroenteritis: on the way to closing the diagnostic gap. J Med Virol. 2003; 70(2): 258-262. Go to original source... Go to PubMed...
  4. Pang X, Honma S, Nakata S, et al. Human caliciviruses in acute gastroenteritis of young children in the community. J Infect Dis. 2000; 181(Suppl 2): S288-294. Go to original source... Go to PubMed...
  5. Guarino A, Albano F, Ashkenazi S, et al. European Society for Paediatric Gastroenterology, Hepatology and Nutrition/ European Sociaety for Paediatric Infectious Diseases Evidence-based Guidelines for Management of Acute Gastroenteritis in Children in Europe. Journal of Ped Gastroent and Nutr. 2008; 46: S81-S184. Go to original source... Go to PubMed...
  6. Soriano-Gabarró M, Mrukowicz J, Vesikari T, et al. Burden of rotavirus disease in European Union countries. Pediatr Infect Dis J. 2006; 25(Suppl 1): 7-11. Go to original source... Go to PubMed...
  7. Parashar U, Christopher G, Bresee J, et al. Rotavirus and severe childhood diarrhea. Emerg Infect Dis. 2006; 12: 304-306. Go to original source... Go to PubMed...
  8. Dormitzer P. Rotaviruses. In: Mandell, Douglas and Bennett´s Principles and Practice of Infectious Diseases, 7th ed. Philadelphia: Churchill Livingstone Elsevier; 2010: 2105-2115. Go to original source...
  9. Rheingans R, Heylen J, Giaquinto C. Economics of rotavirus gastroenteritis and vaccination in Europe. Pediatr Infect Dis J. 2006; 25(1): S48-S55. Go to original source... Go to PubMed...
  10. Diez-Domingo J, Surinach N, Alcalde N, et al. Burden of paediatric rotavirus gastroenteritis (RVGE) and potential benefits of a universal rotavirus vaccination programme with a pentavalent vaccine in Spain. BMC Public Health. 2010; 10: 469. Go to original source... Go to PubMed...
  11. Giaquinto C, Damme P, Huet F, et al. Clinical consequences of rotavirus acute gastroenteritis in Europe, 2004-2005: The REVEAL Study. J of Inf Dis. 2007; 195(1): S26-S35. Go to original source... Go to PubMed...
  12. Vesikari T, Karvonen A, Prymula R, et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, doubleblind controlled study. Lancet 2007, 24; 370(9601): 1757-1763. Go to original source... Go to PubMed...
  13. Krishnarajah G, Davis E, Fan Y, et al. Rotavirus vaccine series completion and adherence to vaccination schedules among infants in managed care in the United States. Vaccine 2012, 21; 30(24): 3717-3722. Go to original source... Go to PubMed...
  14. Raes M, Strens D, Vergison A, et al. Reduction in pediatric rotavirus-related hospitalizations after universal rotavirus vaccination in Belgium. Pediatr Infect Dis J. 2011; 30: e120-125. Go to original source... Go to PubMed...
  15. Paulke-Korinek M, Rendi-Wagner P, Kundi M, et al. Universal mass vaccination against rotavirus gastroenteritis: impact on hospitalization rates in Austrian children. Pediatr Infect Dis J. 2010; 29(4): 319-323. Go to original source...




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.